Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000075.xml
Download PDF
Semin Respir Crit Care Med 2003; 24(2): 151-160
DOI: 10.1055/s-2003-39014
DOI: 10.1055/s-2003-39014
Genetics of Chronic Obstructive Pulmonary Disease
Further Information
Publication History
Publication Date:
07 May 2003 (online)
ABSTRACT
Variability in the susceptibility to develop chronic obstructive pulmonary disease (COPD) is related to both genetic and environmental factors. COPD is likely a genetically complex disease, but severe alpha 1-antitrypsin (AAT) deficiency [e.g., protease inhibitor (PI) Z] remains the only proven genetic risk factor for COPD. Even among PI Z individuals, substantial variability in lung function is observed, suggesting that genetic modifiers may influence the expression of lung disease in severe AAT deficiency. The variable development of COPD in smokers without alpha 1-antitrypsin deficiency and the familial aggregation of lung function measurements also suggest the presence of genetic influences on lung function growth and decline leading to COPD. Many candidate gene loci have been investigated as potential COPD genetic determinants by case-control genetic association studies. However, inconsistent results of these association studies have been frequent. Genetic heterogeneity and population stratification are two potential reasons for the conflicting findings between association studies. Linkage analysis studies have recently been published that may identify regions of the genome that contain COPD susceptibility genes. Future investigations of genetic influences in COPD should consider the use of family-based designs for association studies and the study of positional candidate genes within regions of linkage.
KEYWORDS
COPD - genetics - linkage analysis - association studies - alpha 1-antitrypsin deficiency
REFERENCES
- 1 Lopez A D, Murray C C. The global burden of disease, 1990-2020. Nat Med . 1998; 4 1241-1243
- 2 Burrows B, Knudson R J, Cline M G, Lebowitz M D. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis . 1977; 115 195-205
- 3 Larsson C. Natural history and life expectancy in severe alpha 1-antitrypsin deficiency, PI Z. Acta Med Scand . 1978; 204 345-351
- 4 Eriksson S. Studies in alpha 1-antitrypsin deficiency. Acta Med Scand Suppl . 1965; 432 1-85
- 5 Piitulainen E, Eriksson S. Decline in FEV1 related to smoking status in individuals with severe alpha 1-antitrypsin deficiency (PI ZZ). Eur Respir J . 1999; 13 247-251
- 6 Silverman E K, Pierce J A, Province M A, Rao D C, Campbell E J. Variability of pulmonary function in alpha 1-antitrypsin deficiency: clinical correlates. Ann Intern Med . 1989; 111 982-991
- 7 Silverman E K, Province M A, Campbell E J, Pierce J A, Rao D C. Variability of pulmonary function in alpha 1-antitrypsin deficiency: residual family resemblance beyond the effect of the PI locus. Hum Hered . 1990; 40 340-355
- 8 Black L F, Kueppers F. Alpha 1-antitrypsin deficiency in nonsmokers. Am Rev Respir Dis . 1978; 117 421-428
- 9 Piitulainen E, Tornling G, Eriksson S. Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PI ZZ). Thorax . 1997; 52 244-248
- 10 Novoradovsky A, Brantly M L, Waclawiw M A. et al . Endothelial nitric oxide synthase as a potential susceptibility gene in the pathogenesis of emphysema in alpha 1-antitrypsin deficiency. Am J Respir Cell Mol Biol . 1999; 20 441-447
- 11 Lieberman J, Winter B, Sastre A. Alpha 1-antitrypsin PI-types in 965 COPD patients. Chest . 1986; 89 370-373
- 12 Kauffmann F, Tager I B, Munoz A, Speizer F E. Familial factors related to lung function in children aged 6-10 years: results from the PAARC epidemiologic study. Am J Epidemiol . 1989; 129 1289-1299
- 13 Devor E J, Crawford M H. Family resemblance for normal pulmonary function. Ann Hum Biol . 1984; 11 439-448
- 14 Hubert H B, Fabsitz R R, Feinleib M, Gwinn C. Genetic and environmental influences on pulmonary function in adult twins. Am Rev Respir Dis . 1982; 125 409-415
- 15 Redline S, Tishler P V, Lewitter F I, Tager I B, Munoz A, Speizer F E. Assessment of genetic and nongenetic influences on pulmonary function: a twin study. Am Rev Respir Dis . 1987; 135 217-222
- 16 Williams C, Clymer, M. A Practical Treatise on the Diseases of the Respiratory Organs; Including Disease
of the Larynx, Trachea, Lungs and Pleura. Philadelphia: Lea and Blanchard 1845
MissingFormLabel
- 17 Hurst A. Familial emphysema. Am Rev Respir Dis . 1959; 80 179
- 18 Wimpfheimer F. Familial emphysema. Am Rev Respir Dis . 1961; 83 697
- 19 Larson R K, Barman M L. The familial occurrence of chronic obstructive pulmonary disease. Ann Intern Med . 1965; 63 1001-1008
- 20 Hole B V, Wasserman K. Familial emphysema. Ann Intern Med . 1965; 63 1009-1017
- 21 Larson R K, Barman M L, Kueppers F, Fudenberg H H. Genetic and environmental determinants of chronic obstructive pulmonary disease. Ann Intern Med . 1970; 72 627-632
- 22 Cohen B H, Ball Jr C W, Brashears S. et al . Risk factors in chronic obstructive pulmonary disease (COPD). Am J Epidemiol . 1977; 105 223-232
- 23 Higgins M, Keller J. Familial occurrence of chronic respiratory disease and familial resemblance in ventilatory capacity. J Chronic Dis . 1975; 28 239-251
- 24 Kueppers F, Miller R D, Gordon H, Hepper N G, Offord K. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med . 1977; 63 336-342
- 25 Silverman E K, Chapman H A, Drazen J M. et al . Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease: risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med . 1998; 157(6 pt 1) 1770-1778
- 26 McCloskey S C, Patel B D, Hinchliffe S J, Reid E D, Wareham N J, Lomas D A. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med . 2001; 164(8 pt 1) 1419-1424
- 27 Silverman E K, Palmer L J. Case-control association studies for the genetics of complex respiratory diseases. Am J Respir Cell Mol Biol . 2000; 22 645-648
- 28 Silverman E K, Palmer L J, Mosley J D. et al . Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am J Hum Genet . 2002; 70 1229-1239
- 29 Silverman E K, Mosley J D, Palmer L J. et al . Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes. Hum Mol Genet . 2002; 11 623-632
- 30 Seersholm N, Wilcke J T, Kok-Jensen A, Dirksen A. Risk of hospital admission for obstructive pulmonary disease in alpha 1-antitrypsin heterozygotes of phenotype PI MZ. Am J Respir Crit Care Med . 2000; 161 81-84
- 31 Sandford A J, Chagani T, Weir T D, Connett J E, Anthonisen N R, Pare P D. Susceptibility genes for rapid decline of lung function in the Lung Health Study. Am J Respir Crit Care Med . 2001; 163 469-473
- 32 Dahl M, Nordestgaard B G, Lange P, Vestbo J, Tybjaerg-Hansen A. Molecular diagnosis of intermediate and severe alpha 1-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals. Clin Chem . 2001; 47 56-62
- 33 Poller W, Meisen C, Olek K. DNA polymorphisms of the alpha 1-antitrypsin gene region in patients with chronic obstructive pulmonary disease. Eur J Clin Invest . 1990; 20 1-7
- 34 Kalsheker N A, Watkins G L, Hill S, Morgan K, Stockley R A, Fick R B. Independent mutations in the flanking sequence of the alpha 1-antitrypsin gene are associated with chronic obstructive airways disease. Dis Markers . 1990; 8 151-157
- 35 Sandford A J, Spinelli J J, Weir T D, Pare P D. Mutation in the 3' region of the alpha 1-antitrypsin gene and chronic obstructive pulmonary disease. J Med Genet . 1997; 34 874-875
- 36 Benetazzo M G, Gile L S, Bombieri C. et al . Alpha 1-antitrypsin TAQ I polymorphism and alpha 1-antichymotrypsin mutations in patients with obstructive pulmonary disease. Respir Med . 1999; 93 648-654
- 37 Ohnishi K, Takagi M, Kurokawa Y, Satomi S, Konttinen Y T. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest . 1998; 78 1077-1087
- 38 Finlay G A, O'Driscoll L R, Russell K J. et al . Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med . 1997; 156 240-247
- 39 Shapiro S D. Elastolytic metalloproteinases produced by human mononuclear phagocytes: potential roles in destructive lung disease. Am J Respir Crit Care Med . 1994; 150(6 pt 2) S160-S164
- 40 Minematsu N, Nakamura H, Tateno H, Nakajima T, Yamaguchi K. Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema. Biochem Biophys Res Commun . 2001; 289 116-119
- 41 Joos L, He J Q, Shepherdson M B. et al . The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet . 2002; 11 569-576
- 42 Hirano K, Sakamoto T, Uchida Y. et al . Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease. Eur Respir J . 2001; 18 748-752
- 43 Sandford A J, Chagani T, Weir T D, Pare P D. Alpha 1-antichymotrypsin mutations in patients with chronic obstructive pulmonary disease. Dis Markers . 1998; 13 257-260
- 44 Ishii T, Matsuse T, Teramoto S. et al . Association between alpha 1-antichymotrypsin polymorphism and susceptibility to chronic obstructive pulmonary disease. Eur J Clin Invest . 2000; 30 543-548
- 45 Otterbein L E, Lee P J, Chin B Y. et al . Protective effects of heme oxygenase-1 in acute lung injury. Chest . 1999; 116 (suppl 1) S61-S63
- 46 Choi A M, Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol . 1996; 15 9-19
- 47 Yamada N, Yamaya M, Okinaga S. et al . Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet . 2000; 66 187-195
- 48 Smith C A, Harrison D J. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet . 1997; 350 630-633
- 49 Yoshikawa M, Hiyama K, Ishioka S, Maeda H, Maeda A, Yamakido M. Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese. Int J Mol Med . 2000; 5 49-53
- 50 Yim J J, Park G Y, Lee C T. et al . Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and TI. Thorax . 2000; 55 121-125
- 51 Takeyabu K, Yamaguchi E, Suzuki I, Nishimura M, Hizawa N, Kamakami Y. Gene polymorphism for microsomal epoxide hydrolase and susceptibility to emphysema in a Japanese population. Eur Respir J . 2000; 15 891-894
- 52 Harrison D J, Cantlay A M, Rae F, Lamb D, Smith C A. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Hum Exp Toxicol . 1997; 16 356-360
- 53 Baranova H, Perriot J, Albuisson E. et al . Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis. Hum Genet . 1997; 99 822-826
- 54 Ishii T, Matsuse T, Teramoto S. et al . Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax . 1999; 54 693-696
- 55 Bouma G, Crusius J B, Oudkerk P ool. et al . Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles: relevance for inflammatory bowel disease. Scand J Immunol . 1996; 43 456-463
- 56 Huang S L, Su C H, Chang S C. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med . 1997; 156 1436-1439
- 57 Sakao S, Tatsumi K, Igari H, Shino Y, Shirasawa H, Kuriyama T. Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am J Respir Crit Care Med . 2001; 163 420-422
- 58 Keatings V M, Cave S J, Henry M J. et al . A polymorphism in the tumor necrosis factor-alpha gene promoter region may predispose to a poor prognosis in COPD. Chest . 2000; 118 971-975
- 59 Ishii T, Matsuse T, Teramoto S. et al . Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD. Respir Med . 2000; 94 847-851
- 60 Higham M A, Pride N B, Alikhan A, Morrell N W. Tumour necrosis factor-alpha gene promoter polymorphism in chronic obstructive pulmonary disease. Eur Respir J . 2000; 15 281-284
- 61 Joost O, Wilk J B, Cupples L A. et al . Genetic loci influencing lung function: a genome-wide scan in the Framingham Study. Am J Respir Crit Care Med . 2002; 165 795-799
- 62 Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet . 1995; 11 241-247
- 63 Bartmann K, Fooke-Achterrath M, Koch G. et al . Heterozygosity in the PI-system as a pathogenetic cofactor in chronic obstructive pulmonary disease (COPD). Eur J Respir Dis . 1985; 66 284-296
- 64 Janus E D. Alpha 1-antitrypsin PI types in COPD patients. Chest . 1988; 94 446-447
- 65 Sandford A J, Weir T D, Spinelli J J, Pare P D. Z and S mutations of the alpha 1-antitrypsin gene and the risk of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol . 1999; 20 287-291
- 66 Cantlay A M, Smith C A, Wallace W A, Yap P L, Lamb D, Harrison D J. Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung. Thorax . 1994; 49 1010-1014
- 67 Sundberg K, Johansson A S, Stenberg G. et al . Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis . 1998; 19 433-436
- 68 Patuzzo C, Gile L S, Zorzetto M. et al . Tumor necrosis factor gene complex in COPD and disseminated bronchiectasis. Chest . 2000; 117 1353-1358
- 69 Teramoto S, Ishii T. No association of tumor necrosis factor-alpha gene polymorphism and COPD in Caucasian smokers and Japanese smokers. Chest . 2001; 119 315-316
- 70 Tzetis M, Efthymiadou A, Strofalis S. et al . CFTR gene mutations-including three novel nucleotide substitutions-and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease. Hum Genet . 2001; 108 216-221
- 71 Ho L I, Harn H J, Chen C J, Tsai N M. Polymorphism of the beta-adrenoceptor in COPD in Chinese subjects. Chest . 2001; 120 1493-1499
- 72 Matsushita I, Hasegawa K, Nakata K, Yasuda K, Tokunaga K, Keicho N. Genetic variants of human beta-defensin-1 and chronic obstructive pulmonary disease. Biochem Biophys Res Commun . 2002; 291 17-22
- 73 Landi M T, Bertazzi P A, Shields P G. et al . Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics . 1994; 4 242-246
- 74 Horne S L, Cockcroft D W, Dosman J A. Possible protective effect against chronic obstructive airways disease by the GC2 allele. Hum Hered . 1990; 40 173-176
- 75 Schellenberg D, Pare P D, Weir T D, Spinelli J J, Walker B A, Sandford A J. Vitamin D binding protein variants and the risk of COPD. Am J Respir Crit Care Med . 1998; 157(3 pt 1) 957-961
- 76 Kauffmann F, Kleisbauer J P, Cambon-De-Mouzon A. et al . Genetic markers in chronic air-flow limitation: a genetic epidemiologic study. Am Rev Respir Dis . 1983; 127 263-269
- 77 Sugiyama Y, Kudoh S, Maeda H, Suzaki H, Takaku F. Analysis of HLA antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis . 1990; 141 1459-1462
- 78 Keicho N, Tokunaga K, Nakata K. et al . Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis. Am J Respir Crit Care Med . 1998; 158 846-850
- 79 Vestbo J, Hein H O, Suadicani P, Sorensen H, Gyntelberg F. Genetic markers for chronic bronchitis and peak expiratory flow in the Copenhagen Male Study. Dan Med Bull . 1993; 40 378-380